EPA:VETO • FR0004186856
The current stock price of VETO.PA is 79.9 EUR. Today VETO.PA is up by 0.38%. In the past month the price decreased by -7.98%. In the past year, price increased by 11.17%.
ChartMill assigns a technical rating of 1 / 10 to VETO.PA. When comparing the yearly performance of all stocks, VETO.PA turns out to be only a medium performer in the overall market: it outperformed 62.33% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to VETO.PA. VETO.PA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
11 analysts have analysed VETO.PA and the average price target is 92.41 EUR. This implies a price increase of 15.66% is expected in the next year compared to the current price of 79.9.
Over the last trailing twelve months VETO.PA reported a non-GAAP Earnings per Share(EPS) of 5.04. The EPS increased by 26.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.28% | ||
| ROA | 8.28% | ||
| ROE | 10.59% | ||
| Debt/Equity | 0.02 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 8.96 | 183.392B | ||
| SAN | SANOFI | 9 | 183.103B | ||
| SNW | SANOFI | 8.94 | 183.103B | ||
| UCB | UCB SA | 25.42 | 49.872B | ||
| UNC | UCB SA | 24.23 | 48.472B | ||
| 1MRK | MERCK KGAA | 12.53 | 46.826B | ||
| MRK | MERCK KGAA | 13.31 | 46.804B | ||
| BAYN | BAYER AG-REG | 8.25 | 36.929B | ||
| 1BAYN | BAYER AG-REG | 8.03 | 36.914B | ||
| IPN | IPSEN | 13.16 | 12.923B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.5 | 9.825B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.703B | ||
| VIRP | VIRBAC SA | 16.14 | 2.886B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
IPO: 2006-11-16
VETOQUINOL SA
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
Lure BOURGOGNE-FRANCHE-COMTE FR
Employees: 2519
Phone: 33384625555
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
The current stock price of VETO.PA is 79.9 EUR. The price increased by 0.38% in the last trading session.
VETOQUINOL SA (VETO.PA) has a dividend yield of 1.03%. The yearly dividend amount is currently 0.85.
VETO.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
VETO.PA stock is listed on the Euronext Paris exchange.
VETOQUINOL SA (VETO.PA) has a market capitalization of 949.21M EUR. This makes VETO.PA a Small Cap stock.
VETOQUINOL SA (VETO.PA) will report earnings on 2026-03-18, after the market close.